Literature DB >> 29109499

Cost-Effective but Unaffordable and Unequal Hepatitis C Treatment in the US.

Xibei Liu1, Jay J Shen2, Jeong Lim Lee3, Ji Won Yoo4.   

Abstract

Mesh:

Substances:

Year:  2017        PMID: 29109499     DOI: 10.1038/ajg.2017.210

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  5 in total

1.  Medicaid Reimbursement for Oral Direct Antiviral Agents for the Treatment of Chronic Hepatitis C.

Authors:  Kohtaro Ooka; James J Connolly; Joseph K Lim
Journal:  Am J Gastroenterol       Date:  2017-04-04       Impact factor: 10.864

2.  New Hepatitis C Drugs Are Very Costly And Unavailable To Many State Prisoners.

Authors:  Adam L Beckman; Alyssa Bilinski; Ryan Boyko; George M Camp; A T Wall; Joseph K Lim; Emily A Wang; R Douglas Bruce; Gregg S Gonsalves
Journal:  Health Aff (Millwood)       Date:  2016-10-01       Impact factor: 6.301

3.  Public participation in decision-making on the coverage of new antivirals for hepatitis C.

Authors:  Katharina Kieslich; Jeonghoon Ahn; Gabriele Badano; Kalipso Chalkidou; Leonardo Cubillos; Renata Curi Hauegen; Chris Henshall; Carleigh B Krubiner; Peter Littlejohns; Lanting Lu; Steven D Pearson; Annette Rid; Jennifer A Whitty; James Wilson
Journal:  J Health Organ Manag       Date:  2016-08-15

Review 4.  Direct-Acting Antiviral Agents for Patients With Hepatitis C Virus Genotype 1 Infection Are Cost-Saving.

Authors:  Jagpreet Chhatwal; Tianhua He; Chin Hur; Maria A Lopez-Olivo
Journal:  Clin Gastroenterol Hepatol       Date:  2016-09-17       Impact factor: 11.382

5.  Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.

Authors:  Gillian D Sanders; Peter J Neumann; Anirban Basu; Dan W Brock; David Feeny; Murray Krahn; Karen M Kuntz; David O Meltzer; Douglas K Owens; Lisa A Prosser; Joshua A Salomon; Mark J Sculpher; Thomas A Trikalinos; Louise B Russell; Joanna E Siegel; Theodore G Ganiats
Journal:  JAMA       Date:  2016-09-13       Impact factor: 56.272

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.